Aubière, France

Anne-Lise Glasser

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Lesaffre Et Compagnie. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Lise Glasser. Retrieved from https://idiyas.com/inventor/anne-lise-glasser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Anne-Lise Glasser and Her Contribution to Crohn's Disease Research

Introduction: Anne-Lise Glasser, based in Aubiere, France, is a notable inventor whose work has significantly impacted the medical field, specifically in the diagnosis and treatment of Crohn's disease. With a commitment to advancing healthcare, she holds a patent that addresses a critical aspect of this chronic inflammatory condition.

Latest Patents: Anne-Lise Glasser's patent, titled "Method for diagnosing and treating Crohn's disease," presents an innovative in vitro method for diagnosing the condition. This method involves detecting an overexpression of the CD66c receptor in individuals suffering from Crohn's disease or those predisposed to develop it. Furthermore, the patent outlines potential preventive and curative treatments for the disease, showcasing Glasser's dedication to improving patient outcomes.

Career Highlights: As a key member of Lesaffre et Compagnie, Anne-Lise Glasser has leverages her expertise to further research and development in the field of medical diagnostics and therapeutics. Her career is marked by a focus on innovative solutions that address pressing health concerns, emphasizing the importance of her contribution to Crohn's disease research.

Collaborations: Throughout her career, Anne-Lise Glasser has collaborated with prominent colleagues such as Nicolas Barnich and Arlette Darfeuille-Michaud. These partnerships underscore her commitment to collective advancement in scientific research, enabling the exploration of different facets of Crohn's disease and enhancing the overall efficacy of treatment strategies.

Conclusion: Anne-Lise Glasser exemplifies the innovative spirit necessary for advancements in medical science. With her pioneering patent addressing Crohn's disease, she has made a substantial contribution to the field. Her work not only enhances diagnostic capabilities but also lays the groundwork for future research and development in the treatment of chronic illnesses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…